The highest price Hikma Pharmaceuticals PLC stock has been at in the last year is 2768.00 GBP and its lowest price the last year was 2158.00 GBP.
You can buy Hikma Pharmaceuticals PLC shares with one of the brokers below depending on the type of trading you wish to conduct. You can buy Hikma Pharmaceuticals PLC shares with a broker like eToro or you can trade Hikma Pharmaceuticals PLC CFDs with XTB you can begin trading Hikma Pharmaceuticals PLC shares right away.
If you are buying shares in UK or Europe eToro offer 0% free commission on stocks. This is a big eToro selling point.
when a client buys Hikma Pharmaceuticals PLC stock at 1x leverage with eToro its completely free and they are buying the underlying stock. Also with eToro, clients can buy fractional shares – Min deposit is $200, but $50 is the minimum trade on stocks. eToro are one of the cheapest places to buy stocks.
|Broker||eToro||XTB||IC Markets||AvaTrade||Roboforex||FP Markets|
USA stocks :
UK shares :
CFD trading :
USA stocks :
UK shares :
CFD trading :
USA stocks :
UK shares :
CFD trading :
USA stocks :
UK shares :
CFD trading :
USA stocks :
UK shares :
CFD trading :
USA stocks :
UK shares :
CFD trading :
*losses can exceed deposits when trading Hikma Pharmaceuticals PLC stock CFDs. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. upto 80% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Scroll down to read our indepth article on How To Buy Hikma Pharmaceuticals Shares. What you should know, Types of Hikma Pharmaceuticals PLC stock trading. Pros and Cons, everything is explained below.
You can purchase Hikma Pharmaceuticals PLC shares directly through a brokerage account or one of the various investment applications available. These systems allow you to buy, trade, and keep Hikma Pharmaceuticals PLC stocks from the comfort of your own home or smartphone. The primary distinctions between different Hikma Pharmaceuticals PLC stock trading brokers are primarily in fees and resources supplied. Many of the best Hikma Pharmaceuticals PLC stock trading platforms offer zero commission trading. Make sure you only buy Hikma Pharmaceuticals PLC stock with a well financially regulated Hikma Pharmaceuticals PLC stock broker. You should also spend some time conducting quantitative research (analyse the revenue of Hikma Pharmaceuticals PLC, their net income and earnings) and qualitative research (find out what the Hikma Pharmaceuticals PLC management is like, the competition they face, and how they make money).
When choosing a Hikma Pharmaceuticals PLC stock broker, make sure you consider the variety of exchanges that the broker offers through which to buy and sell individual Hikma Pharmaceuticals PLC stocks and securities, the commissions and fees charged by the broker for conducting trading in Hikma Pharmaceuticals PLC, and what margin rates the broker offers. You will also need to check that you can open a brokerage account with the broker considering your citizenship status.
Several brokers can be extremely expensive for certain types of citizens if they wish to buy Hikma Pharmaceuticals PLC shares once in a while, whereas other brokers offer their services for free. Not every broker you find online will allow you to buy shares of Hikma Pharmaceuticals PLC; this is because they do not have access to the NASDAQ.
You will need a broker that definitely provides you with access to this exchange. In addition, you should factor into your decision the types of research, educational materials, and account types that the online broker offers to help you meet your investing goals.
If you are hoping to invest to fulfil long-term goals, such as a child’s college education or your own retirement, you may wan to buy HIK through a tax-advantaged account, such as an individual retirement account (IRA) or 529. On the other hand, if you require money for larger short-term purposes, such as buying a home or investment property, a taxable investment account may be a more suitable choice.
Finally, make sure you consider the broker's reputation and safety features, as this is highly important. Choose a broker with good reviews or one that is trusted and regulated by a financial regulator.
Full-service Hikma Pharmaceuticals PLC stock brokers personalise their recommendations and charge extra fees, service fees, and commissions. Because of the research and tools that these companies give, most investors are ready to pay these higher costs.
With a Hikma Pharmaceuticals PLC stock discount broker, the investor is responsible for the majority of their own Hikma Pharmaceuticals PLC HIK research. The broker only provides a trading platform and customer support when necessary.
When it comes to trading, risk is the potential that your Hikma Pharmaceuticals PLC investment might fail to deliver any anticipated monetary gains. This could mean receiving lower returns than expected, or losing the original Hikma Pharmaceuticals PLC investment itself. In very particular forms of trading such as Hikma Pharmaceuticals PLC leveraged trades, this may even mean a loss that exceeds the original deposit.
It can seem particularly exciting to buy shares of an company like Hikma Pharmaceuticals PLC, especially one that is as big and well-known as a company such as Hikma Pharmaceuticals PLC. Therefore, you should take a moment to conduct due diligence regarding Hikma Pharmaceuticals PLC and its stock price history. Stocks of Hikma Pharmaceuticals PLC are exposed to credit risk and fluctuations in the value of its investment portfolio. Hikma Pharmaceuticals PLC investments can be negatively affected by credit deterioration, liquidity, political risk, financial results, interest rate fluctuations, market and economic conditions, sovereign risk, or other factors.
In order to mitigate some Hikma Pharmaceuticals PLC trading risks, evaluate the company by reviewing the documents that they are required by law to file regularly. Annual reports, such as the Form 10-K, and quarterly reports (e.g., Form 10-Q) disclose detailed performance and financial information. Typically, they are referred to in the financial press as earnings reports or quarterly earnings.
Finally, in order to make sure the risks are continually monitored, you should review your Hikma Pharmaceuticals PLC position regularly. Monitor your investments by following your own established investment strategy. If you bought a Hikma Pharmaceuticals PLC share with the idea of holding it over the long term, you should participate in the Hikma Pharmaceuticals PLC annual meeting and analyse any news and information about the company.
some Hikma Pharmaceuticals PLC stock brokers are currently offering low or no trading fees for trading Hikma Pharmaceuticals PLC. There is also no account minimum, but there are a variety of promotional offers that you should be aware of before investing in Hikma Pharmaceuticals PLC stock. For instance, eToro is offering commission free stock trading when users sign up for a trading account.
At the time of writing HIK is worth 2434.18 GBP per share.
You can buy Hikma Pharmaceuticals PLC stock in one of two ways: by putting a HIK market order on a stock trading platform, which is executed as soon as possible at the current market price, or by placing a HIK limit order, which allows you to designate the highest price you are ready to pay. Choosing how many Hikma Pharmaceuticals PLC shares to purchase is likely to be a more difficult task and depends greatly on your budget and Hikma Pharmaceuticals PLC investment strategy.
Buying real Hikma Pharmaceuticals PLC shares means you are buy a 100% of each single Hikma Pharmaceuticals PLC HIK share you buy. When you buy a real Hikma Pharmaceuticals PLC stock you own the Hikma Pharmaceuticals PLC stock in your name as an underlying asset. You will have to make sure your trading account has adequete funding to for your Hikma Pharmaceuticals PLC stock bid price.
When you purchase a share of stock in Hikma Pharmaceuticals PLC, you are effectively becoming a part owner of that company. Depending on the volume of Hikma Pharmaceuticals PLC shares you own it may entitle you to certain benefits offered by Hikma Pharmaceuticals PLC. Some companies may choose to pay dividends to shareholders or reinvest income in order to expand further.
Hikma Pharmaceuticals PLC Fractional shares allow for investors to buy a certain portion of a stock. This makes it easier for investors to diversify their portfolio, even with small amounts of money. Fractional shares let investors purchase stock based on a dollar amount that they select rather than a Hikma Pharmaceuticals PLC share's whole price.
Be careful when buying Hikma Pharmaceuticals PLC fractional shares, as they are harder to sell. This is because you need to sell them within the same brokerage account you bought them from, and demand for the purchase of fractional shares is not always at a high point. Fractional shares come in a variety of different increments, so finding a buyer for your Hikma Pharmaceuticals PLC stock and fraction may take longer.
On the other hand, buying Hikma Pharmaceuticals PLC fractional shares do offer an investor increased control over their portfolio. fractional shares can allow a Hikma Pharmaceuticals PLC stock trader to create a strategy based on desired amounts of each stock. Through this type of method, investors can more easily purchase a variety of different stocks that they can then develop into a diversified portfolio.
Fractional shares also pay proportionate dividends. This means that if you own 50% of a Hikma Pharmaceuticals PLC share, you will receive 50% of the dividends that a full share pays. Depending on the broker you use, it is possible to start investing in Hikma Pharmaceuticals PLC with as little as $5 when employing a fractional share investing strategy.
You can buy Hikma Pharmaceuticals PLC fractional shares with eToro.
CFD stands for 'contract for difference'. A CFD is a derivative product that enables traders to trade financial markets, including stocks, Forex, indices and commodities, without having to own the underlying assets. CFD trading lets you speculate on Hikma Pharmaceuticals PLC share prices without having to actually own HIK stock. CFDs are complex investment products and they present a high risk to any trader. There is an ever-present threat of unlimited losses for positions that go wrong. On the other hand, buying CFD share in Hikma Pharmaceuticals PLC can be advantageous if you are a trader with a short-term outlook. This is because CFD trading enables a trader to speculate on the price of an asset by going long (buying) or going short (selling).
CFD trading is quite much like stock trading except when you exchange a CFD you do not actually own any Hikma Pharmaceuticals PLC stock.
If you buy Hikma Pharmaceuticals PLC shares with a stock broker you actually own a share of Hikma Pharmaceuticals PLC. When you trade a contract for difference (CFD) you have an agreement with your CFD broker and are speculating that the Hikma Pharmaceuticals PLC price will change up or down.
Lets explain why you would buy Hikma Pharmaceuticals PLC as a CFD instead of as a share.
If you went and brought 100 Hikma Pharmaceuticals PLC shares at 2434.18 GBP a share with a stock broker you own 200 GBP of Hikma Pharmaceuticals PLC. The main difference when trading Hikma Pharmaceuticals PLC as a CFD and buying Hikma Pharmaceuticals PLC as a share is contracts for difference offer increased leverage.
Contracts for difference are traded on margin which means to have $1000 invested in Hikma Pharmaceuticals PLC you would not need to invest the full amount as you would with a stock broker. You could invest a fraction of the amount ( known as the CFD margin ) with a CFD to hold a similar position in Hikma Pharmaceuticals PLC. Trading an Hikma Pharmaceuticals PLC CFD allows investors to hold larger positions than their invested amount. Be aware that although investing in an Hikma Pharmaceuticals PLC CFD like this amplifies any potential profit. It always exaggerates your potential losses which may exceed your amount invested.
If you invested in an Hikma Pharmaceuticals PLC share with a stock broker you would only lose the amount you invested as you pay the total cost of your position to your broker upfront. There is no leverage.An Hikma Pharmaceuticals PLC CFD long would be hoping to profit from a rise in the Hikma Pharmaceuticals PLC share price. An Hikma Pharmaceuticals PLC CFD short would be aiming to profit from a fall in the Hikma Pharmaceuticals PLC stock price. Trading CFDs allows traders to profit from both directions of the Hikma Pharmaceuticals PLC price on the financial exchange. Giving traders greater chance to move with the financial markets.
With traditional Hikma Pharmaceuticals PLC shares you can only profit from a rise in the Hikma Pharmaceuticals PLC stock price. You can buy Hikma Pharmaceuticals PLC CFD stocks and tradional stocks with eToro or XTB
When investing in Hikma Pharmaceuticals PLC you have several options as to what type of investment you wish to conduct. You can buy traditional Hikma Pharmaceuticals PLC shares with one of our listed brokers or you can trade what is known as CFDs or contracts for difference.
We explain in detail the difference between buying Hikma Pharmaceuticals PLC shares with stock brokers and trading Hikma Pharmaceuticals PLC with CFDs below.
*All values below are estimates and are for illustrative purposes only. Please visit a broker for correct prices.
CFD and Share deals differ from broker to broker so check you are aware of the actual costs with your brokers.
|Hikma Pharmaceuticals PLC CFD trade example||Hikma Pharmaceuticals PLC Share deal example|
|Broker Deal||Invest $486.836 at 1:5 Margin (20%)||Buy at $2434.18 a share|
|Deal size||100 shares||100 shares|
$48683.6(Margin = exposure x 20% margin factor)
$243418(100 shares at $2434.18)
|Close price||Sell at $2921.016||Sell at $2921.016|
(486.836 point increase x 100 shares = $48683.6)
*Not including commission fees and taxes
($292101.6 - $243418 = $48683.6)
*Not including commission fees and taxes
|Trade Hikma Pharmaceuticals PLC CFDs now with XTB||Trade Hikma Pharmaceuticals PLC Shares now with eToro|
When trading in traditional Hikma Pharmaceuticals PLC shares you are limited to when the LSE (The London Stock Exchange) stock exchange is open which is 8:00am to 12:00pm GMT on trading days. You can only buy and sell with your broker when the market is open. With CFD trading you can deal 24/7 around the clock.
Buying shares with a stock broker limits your risk to your initial investment as stock brokers require you to pay for the total amount of your investment. Stock brokers offer no leverage or loans when buying Hikma Pharmaceuticals PLC stock. This limits your risk to your initial amount invested in Hikma Pharmaceuticals PLC. You can only lose the amount invested with traditional Hikma Pharmaceuticals PLC shares. Another benefit of buying Hikma Pharmaceuticals PLC shares with a broker is that you may be eligible to receive Hikma Pharmaceuticals PLC company dividends if applicable.
If you Invest in Hikma Pharmaceuticals PLC via a CFD you have no shareholder privileges as you don't actually own any underlying assets in Hikma Pharmaceuticals PLC. If you buy Hikma Pharmaceuticals PLC stock with a broker you may receive shareholder perks and benefits. There are certain requirements to be eligible for some of these Hikma Pharmaceuticals PLC benefits as in owning a certain amount of stock for a set period.
If you own shares in Hikma Pharmaceuticals PLC you may be eligible to voting rights at Hikma Pharmaceuticals PLC shareholder general meetings.
You should confirm with your local tax office but CFDs are free from capital gains and stamp duty tax in the United Kingdom. When trading CFDs losses can be offset against profits when submitting your tax return.
Investment in Hikma Pharmaceuticals PLC Stocks and shares are only exempt from tax if the Hikma Pharmaceuticals PLC shares were brought through an ISA ( Individual Savings Accounts ) or SIPP ( Self Invested Personal Pensions ).
There are pros and cons to trading in both Hikma Pharmaceuticals PLC Stocks and CFDs. Which is better depends on each investor and a few factors.
Investing in Hikma Pharmaceuticals PLC stocks and shares is better suited for long term investments. Historically Hikma Pharmaceuticals PLC shares provide better returns over the long term, usually a 10 year period.
Hikma Pharmaceuticals PLC CFD trading is more suited to intra day and mid term traders. Wth intra day trading on an Hikma Pharmaceuticals PLC share investors aim to profit on the fluctuating highs and lows of the Hikma Pharmaceuticals PLC price throughout the day. Day trading as you can imagine focuses on profiting from the daily Hikma Pharmaceuticals PLC stock price change.
Both types of trading have different benefits and risks. Make sure you have a good understanding of what you are doing before you invest.
With CFD trading as you can short or long an Hikma Pharmaceuticals PLC stock you can hedge a trade against another trade.
A hedge is an investment that protects the money you have invested from risk. Traders hedge to minimize or offset a loss in value of an Hikma Pharmaceuticals PLC share price for example to a known amount.
If you're thinking about buying Hikma Pharmaceuticals PLC stock, you should first think about how much of your portfolio is already invested in it. If you increase your Hikma Pharmaceuticals PLC holdings, you may be at risk if the company's performance deteriorates, as it has in the past. Furthermore, you may miss out on the benefits of diversification that come from investing in a number of different equities. You should get investing counsel from a financial expert before making any big changes to your portfolio, whether Hikma Pharmaceuticals PLC-related or not.
Focus on developing a well-diversified portfolio that includes stocks, bonds, funds, and alternative assets if you're new to investing. Make sure the money you want to put into the market isn't needed for something else, like building up an emergency fund that can cover at least three months of costs or paying off high-interest debt (like credit cards).
keep in mind that even the best success stories in the market might turn sour. Consumers are notoriously fickle, and another company could emerge in the future to challenge Hikma Pharmaceuticals PLC. Investing in the market itself, rather than picking the hottest stocks at any one time, is a proven long-term approach.
Finally, keep in mind that the Hikma Pharmaceuticals PLC stock's performance in the past may not be an indicator of future Hikma Pharmaceuticals PLC financial market stock price performance.
Total volume is made up of buying volume and selling volume. Buying volume is the number of shares, contracts, or lots that were associated with buying trades, and selling volume is the number that were associated with selling trades. Investors will know when to buy Hikma Pharmaceuticals PLC if they have conducted appropriate research and feel confident that the price of that stock will rise in the short or long term. If they are willing to hold onto the stock until it does, then you will know that it is the right time to buy Hikma Pharmaceuticals PLC stock.
In order to determine if Hikma Pharmaceuticals PLC stock is over or undervalued, one should utilise the P/E ratio. Earnings per share is the amount of a company's net profit divided by the number of outstanding shares. Therefore, the higher the P/E ratio, the more overvalued a stock may be. Conversely, a lower P/E might indicate a more undervalued stock. You should consider the P/E ratio of HIK before investing in Hikma Pharmaceuticals PLC stock.
A Hikma Pharmaceuticals PLC stock is thought to be overvalued when its current price does not line up with its P/E ratio or earnings forecast. For example, if Hikma Pharmaceuticals PLC stock price is 50 times higher its earnings, it is likely to be an overvalued stock compared to one that is trading for 10 times its earnings. Other factors to consider when deciding whether Hikma Pharmaceuticals PLC stock is over or undervalued is the change in HIK fundamentals, the amount of free cash flow that Hikma Pharmaceuticals PLC has, and their price to book ratio. Hikma Pharmaceuticals PLC has a P/E ratio of 16.72.
Founded in 2005, Hikma Pharmaceuticals PLC has a 52 week high price of 2768.00 and a 52 week low price of 2158.00. Hikma Pharmaceuticals PLC has a marketcap of 2,147,483,647 and an average trading volume of 400,817. Hikma Pharmaceuticals PLC has 231,481,628 shares on the LSE (The London Stock Exchange). Hikma Pharmaceuticals PLC has a P/E ratio of 16.72 and a EPS of 1.46.
The P/E ratio aids investors in determining the Hikma Pharmaceuticals PLC stock market value in relation to its earnings. A Hikma Pharmaceuticals PLC high P/E ratio indicates that a stock's price is high in comparison to its earnings and may be overvalued. A Hikma Pharmaceuticals PLC low P/E, on the other hand, may imply that the present stock price is cheap in comparison to earnings.
In layman's terms, you learn how much the market is willing to pay for Hikma Pharmaceuticals PLC stock based on previous and prospective Hikma Pharmaceuticals PLC earnings.
The Hikma Pharmaceuticals PLC current share price (2434.18) divided by its per-share earnings (EPS 1.46) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16.72. In other words, Hikma Pharmaceuticals PLC shares trade at around 16.72x recent earnings. That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 end of 2021 was around (37.69).
The P/E ratio aids investors in determining a stock's market value in relation to its earnings. A high P/E ratio indicates that a stock's price is high in comparison to its earnings and may be overvalued. A low P/E, on the other hand, may imply that the present stock price is cheap in comparison to earnings.
Hikma Pharmaceuticals PLC currently has 231,481,628 active shares in circulation traded through the LON exchange.
Hikma Pharmaceuticals PLC market capitalization is $2,147,483,647 with an average daily trading volume of 400,817 shares.
Trading volume is the amount a security that was traded during over a certain duration. When talking about shares volume refers to the number of shares that have been bought and sold during a given day.
Hikma Pharmaceuticals PLC has a Price Earning Ratio ( PE ) of 16.72 and earning per share ( EPS ) of 1.46. Generally speaking Hikma Pharmaceuticals PLC having a high P/E ratio means that Hikma Pharmaceuticals PLC investors forsee increased growth with Hikma Pharmaceuticals PLC in the future. Companies that are losing money do not have a P/E ratio.
Hikma Pharmaceuticals PLC earnings per share is company profit that's allocated to every Hikma Pharmaceuticals PLC common stock. Earnings per share is calculated by taking the difference between Hikma Pharmaceuticals PLC's net earnings and dividends paid for preferred stock and then dividing that amount by the average amount of Hikma Pharmaceuticals PLC shares outstanding.
A “good” Hikma Pharmaceuticals PLC P/E ratio isn't always a high or low ratio in and of itself. A higher Hikma Pharmaceuticals PLC PE ratio than that may be regarded bad, while a lower Hikma Pharmaceuticals PLC PE ratio could be considered better. The market average P/E ratio now runs from 20 to 25, thus a higher PE ratio above that could be considered bad, while a lower Hikma Pharmaceuticals PLC PE ratio could be considered better.
EPS is a widely used indicator for measuring Hikma Pharmaceuticals PLC stock price value since it shows how much money Hikma Pharmaceuticals PLC produces for each share of its stock. Investors will pay more for a Hikma Pharmaceuticals PLC share if they believe Hikma Pharmaceuticals PLC profits are higher than the Hikma Pharmaceuticals PLC stock price, so a higher Hikma Pharmaceuticals PLC EPS signals more value.
Hikma Pharmaceuticals PLC has an earnings per share (EPS) value of 1.46.
Stocks with EPS growth rates of at least 25% over the previous year's levels indicate that a company's products or services are in high demand. If the EPS growth rate has been increasing in recent quarters and years, that's even better.
The PEG ratio, or price/earnings-to-growth ratio, is a measure that helps investors value a business by taking into consideration the company's market price, earnings, and future growth potential. The PEG ratio can show if a stock is overvalued or undervalued in a more comprehensive way.
Hikma Pharmaceuticals PLC share price/earnings-to-growth ratio is computed by dividing its P/E ratio by its growth. A PEG ratio greater than one indicates that shares are overvalued at their current rate of growth, or that they may predict a faster rate of growth.
The PEG ratio, rather just the P/E ratio, provides a more comprehensive picture of Hikma Pharmaceuticals PLC's potential profitability. It could also assist you compare the share prices of different high-growth firms by accounting for growth.
Hikma Pharmaceuticals PLC stock trading volume can assist an investor in determining the strength of Hikma Pharmaceuticals PLC stock price momentum and confirming a trend. Hikma Pharmaceuticals PLC stock prices tend to move in the same direction as Hikma Pharmaceuticals PLC trade volume increases. If a Hikma Pharmaceuticals PLC stock price continues to rise in an uptrend, Hikma Pharmaceuticals PLC stock trading volume should rise as well, and vice versa.
Hikma Pharmaceuticals PLC has a trading volume of 400,817
The sentiment driving Hikma Pharmaceuticals PLC stock price movement is measured by Hikma Pharmaceuticals PLC trading volume. It informs you of the number of persons involved in the Hikma Pharmaceuticals PLC stock price movement. When Hikma Pharmaceuticals PLC stock trades on low volume, it signifies that only a small number of people are involved in Hikma Pharmaceuticals PLC stock buying and selling transactions. The market interest in Hikma Pharmaceuticals PLC stock can be measured by its trading volume.
The Hikma Pharmaceuticals PLC stock price has fluctuated in value during the last year, ranging from 2158.00 GBP to 2768.00 GBP. The larger the range between the 52 week low and 52 week high price is a prominent metric for determining its volatility.
Once you have found your Hikma Pharmaceuticals PLC stock broker, opened an account and deposited money, you will be ready to begin investing in Hikma Pharmaceuticals PLC stocks.
From this point onwards, you will have to navigate to the stock within your trading app or on a browser, enter the amount of shares (or dollars you would like to invest with fractional shares) you want to buy, select your preferred order type (e.g., market, limit, etc.) and execute the trade.
For greater control of your money and Hikma Pharmaceuticals PLC shares, you may wish to use a limit order as opposed to a simple market order. Limit orders will allow you to specify the price at which you would like to buy Hikma Pharmaceuticals PLC stock, while market orders automatically execute at the price available from sellers.
In thinly traded securities with large bid-ask spreads, this can result in a fairly sizable difference between what you see the stock trading for and what you actually pay. On your brokerage platform, input a request to buy HIK stock at the best current price, or use a more advanced order type mentioned like limit or stop orders. These help purchase shares once the stock price falls below a certain threshold.
Hikma Pharmaceuticals PLC is traded on the LSE (The London Stock Exchange) exchange meaning that it can be bought or sold between the LSE (The London Stock Exchange) trading hours which are 8:00am to 12:00pm GMT.
You may be able to access this service through your online Hikma Pharmaceuticals PLC brokerage. The LSE (The London Stock Exchange) pre-market trading hours terms are 5:05 a.m. and 7:50 a.m. GMT, and after-hours trading conditions are 4:40 p.m. to 5:15 p.m. GMT. If you place an Hikma Pharmaceuticals PLC stock order outside of available LSE (The London Stock Exchange) trading hours it will be processed once LSE (The London Stock Exchange) trading resumes.
Hikma Pharmaceuticals PLC stock market prices are primarily affected by supply and demand economics. In simple terms, when demand for Hikma Pharmaceuticals PLC stock exceeds supply, there is often seen a rise in the price of a stock. The more drastic the demand-supply gap, the higher the Hikma Pharmaceuticals PLC stock price. When there is more Hikma Pharmaceuticals PLC available than people want to buy, however, the price of HIK will go down. When there is not enough Hikma Pharmaceuticals PLC stocks for everyone who wishes to buy them, its price will go up. The price of Hikma Pharmaceuticals PLC stock fluctuates based on the number of people who want to buy Hikma Pharmaceuticals PLC stock versus shares those stocks that are available for sale.
The release of an innovative and revenue-driving products or services is one way that Hikma Pharmaceuticals PLC has influenced the HIK stock valuation.
The Hikma Pharmaceuticals PLC market capitalisation (or "Hikma Pharmaceuticals PLC market cap") of a Hikma Pharmaceuticals PLC stock is calculated by multiplying the total number of shares outstanding by the Hikma Pharmaceuticals PLC share price. If a corporation has one million outstanding shares priced at $50 apiece, its market capitalization is $50 million. Hikma Pharmaceuticals PLC has a market cap of 2,147,483,647.
Knowing the marketcap of Hikma Pharmaceuticals PLC allows you to analyse a company in the context of like sized companies in its industry, market cap has greater meaning than share price. A small-cap firm with a $500 million market capitalization should not be compared to a large-cap corporation with a market value of $10 billion.
Hikma Pharmaceuticals PLC volume is counted as the total number of Hikma Pharmaceuticals PLC shares that are actually traded (bought and sold) during the trading day or specified set period of time. It is a measure of the total turnover of Hikma Pharmaceuticals PLC shares, and while the same Hikma Pharmaceuticals PLC shares may be traded back and forth multiple times, the overall volume of Hikma Pharmaceuticals PLC stocks is counted during each transaction. The high volume of Hikma Pharmaceuticals PLC stocks is an indicator of its market strength. This is because rising markets with an increasing volume are typically viewed as financially healthy.
The number of Hikma Pharmaceuticals PLC shares bought and sold each day in any given financial instrument, known as volume. Volume is one of the most accurate ways of gauging the money flow of Hikma Pharmaceuticals PLC. Because Hikma Pharmaceuticals PLC is appreciating on high volume, it demonstrates investing in HIK as a sustainable move. If you see Hikma Pharmaceuticals PLC stock appreciating on low volume, it could be an unwise move to invest in it. When more money is moving a stock price, it means there is more demand for that stock.
The stock price of Hikma Pharmaceuticals PLC has nothing to do with its worth. Because the Hikma Pharmaceuticals PLC share price represents nothing on its own, a 2434.18 stock could be more valuable than a 24341.8 stock.
What decides whether a stock is overvalued or undervalued is the relationship between price-to-earnings and net assets. Companies can artificially keep stock prices high by avoiding doing stock splits, but they will lack the underlying basic underpinning. Make no judgments based just on the pricing.
Dividends are payments made to shareholders on a quarterly basis by many companies. Dividend investing is the practise of building a portfolio of stocks that pay dividends on a regular basis over time. These stocks provide a steady source of passive income, which can be useful in retirement.
However, you can't judge a stock only on its dividend. When the underlying company is in jeopardy, companies will sometimes increase dividends to entice investors.
There is a big difference between Hikma Pharmaceuticals PLC stock value and Hikma Pharmaceuticals PLC stock price. The price of Hikma Pharmaceuticals PLC stock only tells you the company's current value or its market value. So, this price represents how much Hikma Pharmaceuticals PLC stock trades at, otherwise known as the price agreed upon by a buyer and a seller. On the other hand, the intrinsic value of HIK is the Hikma Pharmaceuticals PLC stock actual worth in dollars. In simple terms, Hikma Pharmaceuticals PLC price is what you pay for the Hikma Pharmaceuticals PLC stocks you acquire and Hikma Pharmaceuticals PLC value is what the Hikma Pharmaceuticals PLC company gives you in goods or services, i.e., their worth. The value of Hikma Pharmaceuticals PLC tends to be more important for investors, but Hikma Pharmaceuticals PLC price matters more for traders who wish to buy and sell HIK
While there is no set quantity of Hikma Pharmaceuticals PLC stocks that every investor should own, there are some guidelines to follow. The general rule is to strive to obtain adequate diversification in your portfolio to protect yourself from losses while not overstretching your investments. The number of stocks that will help you attain your goal is the appropriate number for budget and investment strategy.
It's just as vital to know when to sell Hikma Pharmaceuticals PLC as it is to buy Hikma Pharmaceuticals PLC stocks. Most investors purchase when the stock market is rising and sell when it is falling, but a sensible investor uses a plan that is tailored to their specific financial goals.
If they enter a Hikma Pharmaceuticals PLC correction or a crash, don't be alarmed. These occurrences rarely persist long, and history has shown that the market will eventually recover. Losing money is never nice, but it's a good idea to ride through the downturn and keep your assets because they'll most likely increase again over the very long term.
Stock market investments have historically provided much higher returns than savings accounts, making them the favoured method for increasing your retirement savings. Some stocks are more volatile than others so if you want to buy a specific stock like Hikma Pharmaceuticals PLC as part of your retirement portfolio you will have to do you own research on its long term volatility. Stocks can provide tax-advantaged growth of your investment funds, but you get to choose whether you want a tax cut now or later. Investing in any stock like Hikma Pharmaceuticals PLC as a retirement strategy in a very long term investment strategy. At least over 10 years.
Before you can begin buying and selling Hikma Pharmaceuticals PLC stocks, you must first comprehend the various sorts of Hikma Pharmaceuticals PLC stock orders and when each is appropriate. We explain the various types of Hikma Pharmaceuticals PLC stock orders below.
A Hikma Pharmaceuticals PLC market order is a instant purchase or sale of a Hikma Pharmaceuticals PLC stock at the current best available price on the market. A market order almost always guarantees execution, but not at a certain Hikma Pharmaceuticals PLC stock price. When the primary purpose is to execute a Hikma Pharmaceuticals PLC stock trade as soon as possible, market orders are the best option.
One of the most significant advantages of a Hikma Pharmaceuticals PLC stock market order is that it allows an Hikma Pharmaceuticals PLC investor to enter the Hikma Pharmaceuticals PLC stock at any moment. The Hikma Pharmaceuticals PLC stock buyer need not wait for the order to be completed. A Hikma Pharmaceuticals PLC stock market order has an almost 100 percent likelihood of being carried out. The Hikma Pharmaceuticals PLC stock market order will almost likely be fulfilled as long as there are Hikma Pharmaceuticals PLC stock buyers and sellers.
The most significant disadvantage of a Hikma Pharmaceuticals PLC stock market order is that you cannot define the Hikma Pharmaceuticals PLC trade's price. If the Hikma Pharmaceuticals PLC price moves quickly, you may find yourself trading at a price that is much different from what you paid when you placed the Hikma Pharmaceuticals PLC stock order. Be careful of high Hikma Pharmaceuticals PLC stock price volatility and low Hikma Pharmaceuticals PLC stock liquidity and trading volume.
A Hikma Pharmaceuticals PLC limit order is an order to buy or sell a security at a specific price or better. A buy limit order can only be executed at the limit price or lower, and a sell limit order can only be executed at the limit price or higher. A limit order is not guaranteed to execute. For instance, if you wish to buy Hikma Pharmaceuticals PLC shares for no more than $10, you could submit a limit order for this amount and the order will only execute if the price of Hikma Pharmaceuticals PLC stock is $10 or lower. It should be noted that even if Hikma Pharmaceuticals PLC stock reaches the specified limit price set by an investor, the order may not be filled as there may be orders ahead that eliminate the availability of shares at the limit price. In this way, Hikma Pharmaceuticals PLC stock limit orders are executed on a first-come, first served basis. Also note that with a limit order, the price at which the order is executed can be lower than the limit price, in the case of a buy order, or higher than the limit price, in the case of a sell order.
Using limit orders when purchasing Hikma Pharmaceuticals PLC stock can be beneficial if it is thinly traded, highly volatile, or has a wide bid-ask spread: the difference between the highest price a buyer is willing to pay for an asset in the market and the lowest price a seller is willing to accept. As well as this, a limit order can help if you are looking to receive a specific price for your Hikma Pharmaceuticals PLC stock. It will ensure that the trade does not happen unless you get that price or better. You are able to wait for your price.
A buy limit order does not guarantee execution of your Hikma Pharmaceuticals PLC stock. Execution only occurs when the asset's price trades down to the limit price, and a sell order transacts according to the buy limit order. In this way, you are not guaranteed to trade Hikma Pharmaceuticals PLC stock. If the stock never reaches the set limit price, the trade will not execute. Even if the Hikma Pharmaceuticals PLC stock hits your set limit, there may not be enough demand or supply to fill the order. This is, however, more likely for small, illiquid stocks.
An Hikma Pharmaceuticals PLC stop order, also referred to as a stop-loss order, is an order to buy or sell a stock at the point in which the price of the Hikma Pharmaceuticals PLC stock reaches a specified price. This is known as the stop price. When the stop price is reached, a stop order becomes a market order. A buy stop order is entered at a stop price above the current market price. A stop order is therefore a type of instruction to trade Hikma Pharmaceuticals PLC shares if its price becomes lower than a specific price that is set, known as the stop price. For example, a stop order at $50 placed by the owner of Hikma Pharmaceuticals PLC stock currently trading at $53 means that it will sell this stock at the market price if the stock price hits $50.
The main advantage of using a stop order when purchasing or selling Hikma Pharmaceuticals PLC stock is that it provides you with the ability to enter or exit your Hikma Pharmaceuticals PLC stock trades at a future stop price which you can set. The primary benefit of a stop-limit order on your Hikma Pharmaceuticals PLC stock, therefore, is that you can control the price at which the HIK order can be executed. Investors should use a stop order to limit a loss on their Hikma Pharmaceuticals PLC stock or to protect a profit on it that they have sold short.
The main disadvantage of a Hikma Pharmaceuticals PLC stock stop order is that it functions like a Market order and does not guarantee the price that you set it at. This depends on the asset's availability at each price level at the moment of execution. Short-term fluctuation in Hikma Pharmaceuticals PLC stock's price could activate the stop price that is set, which is a big disadvantage. The key to success is picking a stop-loss percentage that allows Hikma Pharmaceuticals PLC stock to fluctuate day-to-day, while also preventing as much downside risk as possible. In addition, investors have to make the call themselves on whether or not to take a call on Hikma Pharmaceuticals PLC stock stop orders, meaning that they could sell stocks too soon, or too late. Finally, stop-loss orders used on Hikma Pharmaceuticals PLC stock can also trigger a stock sale, even if the price of Hikma Pharmaceuticals PLC stock dips slightly below the trigger price before quickly recovering.
A buy stop order on Hikma Pharmaceuticals PLC stock is entered at a stop price above the current market price. Investors generally use such a technique to limit a loss or to protect a profit on a stock that they have sold short. Hikma Pharmaceuticals PLC stock buy orders are the price levels set by a trader when they wish to buy Hikma Pharmaceuticals PLC assets in the future. A sell stop order is entered at a stop price below the current market price of Hikma Pharmaceuticals PLC stock. An Hikma Pharmaceuticals PLC stock sell order is the price level set by a trader when they wish to sell an asset in the future.
It is crucial to periodically review your Hikma Pharmaceuticals PLC investment portfolio and its performance. Once you have bought your Hikma Pharmaceuticals PLC stock alongside other suitable investments, you can use stock tracking apps to follow its progress over time.
Evaluate the performance of your Hikma Pharmaceuticals PLC stock by looking at their annual percent return. This will allow you to compare your Hikma Pharmaceuticals PLC stocks with other investments and gauge how well your investment has performed. You may also wish to look back at the fundamental data gathered at an earlier date to see how it has developed over time. You can compare the information gathered about Hikma Pharmaceuticals PLC stocks to other stocks or benchmarks, such as the S&P 500 and NASDAQ Index.
By analysing these benchmarks you are able to obtain an idea of how your Hikma Pharmaceuticals PLC investment is performing relative to certain industries or the market as a whole. For instance, if you bought Hikma Pharmaceuticals PLC shares in the hope of holding it for a long period of time, you could participate in annual meetings find out about any important news with regards to the company.
If you plan to sell your Hikma Pharmaceuticals PLC stock shortly after witnessing an increase in its price, you may wish to use different position management tools. For instance, you can set a target price at which you want to sell your Hikma Pharmaceuticals PLC share for a profit, or use a stop-loss tool to set a price at which you want to sell a Hikma Pharmaceuticals PLC share to avoid further losses.
Our team have listed brokers that match your criteria for you below. All brokerage data has been summarised into a comparison table. Scroll down.
|Hikma Pharmaceuticals PLC Stock symbol||HIK|
|Hikma Pharmaceuticals PLC Sector and Industry||Consumer Goods Pharmaceuticals|
|Hikma Pharmaceuticals PLC Exchange||LON -|
|Current Hikma Pharmaceuticals PLC Stock Price (*delayed)||$2434.18|
|Stock Open Price||$2423.00|
|52 Week High||$2768.00|
|52 Week Low||$2158.00|
|Hikma Pharmaceuticals PLC Market Capitalisation||2,147,483,647|
|Hikma Pharmaceuticals PLC Average Volume||400,817|
|Hikma Pharmaceuticals PLC PE||16.72|
|Hikma Pharmaceuticals PLC EPS||1.46|
Hikma Pharmaceuticals PLC is an American Consumer Goods Pharmaceuticals company currently traded on the LON which fully known as the .
Hikma Pharmaceuticals PLC trades under the stock symbol HIK on the LON.
Hikma Pharmaceuticals PLC shares are exchanged in USD on the LON.
Hikma Pharmaceuticals PLC has a current share price of $2434.18 USD dated 31/01/2020.
The highest Hikma Pharmaceuticals PLC share price over the last 52 weeks was $2768.00 USD and its lowest price over the last 52 weeks was $2158.00 USD. That is a 52 week price range of $2158.00 - $2768.00.
|Hikma Pharmaceuticals PLC Employees||8,681|
|Hikma Pharmaceuticals PLC IPO|
|Hikma Pharmaceuticals PLC Head Quarters||1 New Burlington Place, LONDON, UNITED KINGDOM-NA, W1S 2HR GB|
|Hikma Pharmaceuticals PLC Industry||Consumer Goods - Pharmaceuticals|
|CEO||Mr. Sigurdur Olafsson|
We compare multiple aspects of brokers to help you make a more education decision when investing in Hikma Pharmaceuticals PLC.
How To Buy Hikma Pharmaceuticals Shares Table of Contents